Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-11-2
pubmed:abstractText
We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1522-726X
pubmed:author
pubmed:copyrightInfo
Copyright 2009 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
719-27
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19530147-Aged, pubmed-meshheading:19530147-Angioplasty, Balloon, Coronary, pubmed-meshheading:19530147-Cardiovascular Agents, pubmed-meshheading:19530147-Cardiovascular Diseases, pubmed-meshheading:19530147-Coronary Angiography, pubmed-meshheading:19530147-Coronary Artery Disease, pubmed-meshheading:19530147-Coronary Restenosis, pubmed-meshheading:19530147-Drug-Eluting Stents, pubmed-meshheading:19530147-Female, pubmed-meshheading:19530147-Humans, pubmed-meshheading:19530147-Kaplan-Meier Estimate, pubmed-meshheading:19530147-Linear Models, pubmed-meshheading:19530147-Logistic Models, pubmed-meshheading:19530147-Male, pubmed-meshheading:19530147-Middle Aged, pubmed-meshheading:19530147-Myocardial Infarction, pubmed-meshheading:19530147-Paclitaxel, pubmed-meshheading:19530147-Prospective Studies, pubmed-meshheading:19530147-Prosthesis Design, pubmed-meshheading:19530147-Risk Assessment, pubmed-meshheading:19530147-Risk Factors, pubmed-meshheading:19530147-Sex Factors, pubmed-meshheading:19530147-Single-Blind Method, pubmed-meshheading:19530147-Sirolimus, pubmed-meshheading:19530147-Thrombosis, pubmed-meshheading:19530147-Time Factors, pubmed-meshheading:19530147-Treatment Outcome, pubmed-meshheading:19530147-Women's Health
pubmed:year
2009
pubmed:articleTitle
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
pubmed:affiliation
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA. alansky@crf.org
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't